The characteristic features of the relationship of thyroid, hemostasis and lipid peroxidation
DOI:
https://doi.org/10.15587/2313-8416.2015.54811Keywords:
hemostasis, peroxide, antioxidant, coagulation, platelets, hypothyroidism, pro-coagulating, aggregative, hormones, glandAbstract
In recent years, it is experimentally confirmed the change of activity of blood coagulation factors in hypothyroidism, connection of lipid peroxidation-thyroid (LP-T) with hemostasis: T3 inhibits peroxidation in microsomal fraction of hepatocytes thyroliberyn limits the accumulation of LP products, concentration of enzymes-antioxidant varies at different stages of thyroid lesions, especially in thyroid oncology - accumulation of LP products. This indicates that the thyroid regulates the LP processes and its operation depends on the LP
References
Pan'kiv, V. I. (2011). Praktychna tyreoi'dologija. Donec'k, 223.
Jangolenko, V. V., Okorokov, A. N. (1991). Uroven' v krovy srednemolekuljarnih peptydov y aktyvnost' perekysnogo okyslenyja lypydov v dyfferencyal'noj dyagnostyke dyffuznogo toksycheskogo zoba. Probl. Endokrynologyy, 37 (1), 10–12.
Kramann, B., Defreyne, L., Schneider, G. et. al (1997). Percutaneous embolization therapy in severe cervicofacial hemorrhages. Rofo Fortschr. Geb Romtgenstr Neuen Bildgeb Verfahr, 166 (1), 54–61.
Masunaga, R., Nagasaka, A., Nakai, A., Kotake, M., Sawai, Y., Oda, N. et. al (1997). Alteration of platelet aggregation in patients with thyroid disorders. Metabolism, 46 (10), 1128–1131. doi: 10.1016/s0026-0495(97)90203-1
Morishita, E., Nakao, S., Asakura, H., Jokaji, H., Saito, M., Uotani, C. et. al (1996). Hypercoagulability and high lipoprotein(a) levels in patients with aplastic anemia receiving cyclosporine. Blood Coagulation & Fibrinolysis, 7 (6), 609–614. doi: 10.1097/00001721-199609000-00006
Danilova, L. I. (2005). Bolezni shhitovidnoj zhelezy i associirovannye snimi zabolevanija. Minsk: Nagasaki, 470.
Shabanov, Je. A. (2000). Vlijanie jetiniljestradiola i levonorgestrela na intensivnost' vnutrisosudistogo svertyvanija krovi i koaguljacionnuju aktivnost' trombocitov. Perm, 20.
Shapovalov, P. Ja. (2000). Vlijanie jestrogena (jetiniljestradiola) i gestagena (levonorgestrela) na gemostaz. Tromboz, gemostaz i reologija, 2, 28–33.
Byshevskij, A. Sh., Muhacheva, I. A., Shafer, V. M. (30.06.91). Sposob opredelenija soderzhanija produktov degradacii fibrina v plazme 1659855. Bjul. № 24.
Fitch, C. A., Song, Y., Levenson, C. W. (1999). Developmental Regulation of Hepatic Ceruloplasmin mRNA and Serum Activity by Exogenous Thyroxine and Dexamethasone. Proceedings of the Society for Experimental Biology and Medicine, 221 (1), 27–31. doi: 10.1046/j.1525-1373.1999.d01-50.x
Gomba, S., Gautier, A., Lemarchand-Buraud, T., D. (1975). Gardiol Pigmentation and dysfunction of Gunn rat thyroid:correlation between morphological and biochemical data. Virchows Arch. B Cell Pathol,11 (20), 41–54.
Bozhko, A. P., Gorodetskaia, I. V., Solodkov, A. P. (1990). Restriction of stressinduced activation of lipid peroxidation by small doses of thyroid hormones. Bull. Exp. Biol. Med.,109 (6), 539–541.
Shevljukova, T. P. (2000). Narushenija gemostaza pri pozdnem gestoze i ih korrekcija antioksidantami i antiagregatami. Tomsk, 40 s.
Gupta, P., Kar, A. (1998). Role of ascorbic acid in cadmium-induced thyroid dysfunction and lipid peroxidation. Journal of Applied Toxicology, 18 (5), 317–320. doi: 10.1002/(sici)1099-1263(1998090)18:5<317::aid-jat514>3.0.co;2-u
Mono, T., Shinohara, R., Iwase, K., Kotake, M., Hamada, M., Uchimura, K. et. al (1997). Changes in Free Radical Scavengers and Lipid Peroxide in Thyroid Glands of Various Thyroid Disorders. Hormone and Metabolic Research, 29 (07), 351–354. doi: 10.1055/s-2007-979052
Bishevs'kij, A. Sh., Galjan, S. L., Tazhudinova, S. I. et. al (1995). Gemokoaguljacionnaja aktivnost' belkovogo komponenta gemoglobina. «Fiziologija perekisnogo okislenija lipidov, gemostaza i immunogeneza». Poltava, 8–9.
Bech, K., Damsbo, P., Eldrup, E., Beck-Nielsen, H., Røder, M. E., Hartling, S. G. et. al (1996). β-Cell function and glucose and lipid oxidation in Graves’ disease. Clinical Endocrinology, 44 (1), 59–66. doi: 10.1046/j.1365-2265.1996.636458.x
Rom-Bugoslavskaia, E. S., Somova, E. V., Grichenko, T. S. et. al (1998). Lipid peroxidation in patients with diffuse toxic goiter and hypothyroidism. Lik Sprava, 1, 88–91.
Baran, I. V., Franchuk, M. M., Dem’janenko, S. M. (1993). Korekcija perekysnogo okyslennja lipidiv u hvoryh dyfuznym toksychnym zobom. Fiziologija i patologija POL, gemostazu i imunogenezu. Poltava, 36.
Mutaku, J. (1998). Antigoitrogenic effect of combined supplementation with dl-alpha-tocopherol, ascorbic acid and beta-carotene and of dl-alpha-tocopherol alone in the rat. Journal of Endocrinology, 156 (3), 551–561. doi: 10.1677/joe.0.1560551
Koz, R. K., Akdemir, H., Kurtsoy, A. (1995). Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba,TRH and methylprednisolone. Res. Exp. Med., 195 (2), 117–123.
Costantini, F., Pierdomenico, S. D., Cesare, D. D., De Remigis, P., Bucciarelli, T., Bittolo-Bon, G. et. al (1998). Effect of Thyroid Function on LDL Oxidation. Arteriosclerosis, Thrombosis, and Vascular Biology, 18 (5), 732–737. doi: 10.1161/01.atv.18.5.732
Marzoev, A. I., Klebanov, G. I., Shersnev, M. P., Andrjushhenko, A. P. (1985). Perekisnoe okislenie lipidov syvorotki krovi krolikov s razlichnym tireoidnym sostojaniem. Vopr. med. Himii, 31 (2), 14–17.
Baluda, V. P., Barkagan, Z. S., Gol'dber, E. D. et. al (1980). Laboratornye metody issledovanija sistemy gemostaza. Tomsk, TGU, 310.
Balabolkin, M. I. (1989). Jendokrinologija. Moscow: Medicina, 416.
Bozhko, A. P., Gorodeckaja, I. V. (1994). Znachenie tireoidnyh gormonov v realizacii zashhitnyh jeffektov holodovoj adaptacii. Patofiziologija i eksperimental'naja terapija, 4, 29–32.
Bokarev, I. N. (2000). Aterotromboz – problema sovremennosti. Tromboz, gemostaz i reologija, 1, 6–7.
Byshevskij, A. Sh., Solov'ev, V. G., Selivanova, I. V. (1996). Patent na izobretenie «Sposob kolichestvennogo opredelenija obshhej koagulirujushhej aktivnosti trombocitov». № 2061953; pub. 10.06.1996. Bjull. № 16.
Vadzjuk, S. N. (1992). Vlyv konvaflavinu na perekysne okyslennja lipidiv v serci pry eksperymental'nomu tyreotoksykozi. Eskperym. y klynycheskaja farmakologyja, 55, 34–35.
Volkov, A. Y. (2000). Gemokoaguljacyja y trombocytarnij gemostaz pry DTZ. Vol. 2. Kyrov, 13.
Vlasyk, L. I., Zal'cman, N. K., Kuharchuk, O. L. (2001). Vplyv liotyroninu na intensyvnist' peroksydnogo okyslennja lipidiv u vnutrishnih organah shhurjat, materi jakyh pid chas vagitnosti i laktacii' zaznaly vplyvu vazhkyh metaliv. «Mehanizmy fiziologichnyh funkcij v eksperymenti ta klinici». Lviv, 22.
Gur'janov, A. I. (1969). Koaguljacionnye svojstva krovi pri jeksperimental'nom gipo- i atireoze. Sistema svertyvanija krovi i fibrinoliz. Kyiv, 41–42.
Georgieva, S. I. (1975). Gormony, tkanevye i kletochnye mehanizmy sistemy gemostaza. Sistema svertyvanija krovi i fibrinoliz. Saratov, 35–39.
Kovalev, M. M., Vakulenko, S. N. (1969). Rol' shhitovidnoj zhelezy v reguljacii processa svertyvanija krovi. Sistema svertyvanija krovi i fibrinoliz. Kyiv, 301.
Kamyshnikov, V. S. (2009). Spravochnik po kliniko-biohimicheskim issledovanijam i laboratornoj diagnostike. Moscow: «MEDpress-inform», 889.
Mamikonjan, M. I., Hubecova, R. D., Pashajan, S. G. (1969). K voprosu o sootnoshenii izmenenij gemostaza i nekotoryh pokazatelej lipidnogo obmena. Sistema svertyvanija krovi i fibrinoliz. Kyiv, 101.
Mishhenko, V. P. (1981). Perekisnoe okislenie lipidov, antioksidanty i svertyvaemost' krovi. Aktual'nye problemy gemostaziologii. Moscow: Nauka, 153–157.
Zajko, N. N., Bycja, Ju. V. (Ed.) (2007) Patologicheskaja fiziologija. Moscow: «MEDpress-inform», 635.
Rachjov, R. R., Eshhenko, N. D. (1987). Tireoidnye gormony i subkletochnye strutury. Moscow: Medicina, 493.
Shrejber, B. (1987). Patofiziologija zhelez vnutrennej sekrecii. Praga, 493.
Chaurasia, S. S., Kar, A. (1997). Protective effects of vitamin E against lead-induced deterioration of membrane associated type-I iodothyronine 5′-monodeiodinase (5′D-I) activity in male mice. Toxicology, 124 (3), 203–209. doi: 10.1016/s0300-483x(97)00155-8
Shved, M. I., Pasjechko, N. V., Martynjuk, L. P. et. al (2006). Klinichna endokrynologija v shemah i tablycjah. Ternopil': TDMU «Ukrmedknyga», 344.
Olijnyk, V. A. (2001). Patologija shhytovydnoi' zalozy v Ukrai'ni (epidemiologija ta regional'ni osoblyvosti). Zhurnal praktychnogo likarja, 2, 5–7.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Ольга Федорівна Мисник
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
